Evidence map›Paper›PMID 26900275›Full record

ReviewJournal of clinical and experimental hepatology2015

Liver Transplantation in India: At the Crossroads.

Sanjay Nagral, Aditya Nanavati, Aabha Nagral

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical and experimental hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Heart transplantation in India-are we there yet?Indian journal of thoracic and cardiovascular surgery · 2020
    Article
  7. Article
  8. Article
  9. Quality of life of liver donors following donor hepatectomy.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2017
    Article
  10. Article
  11. Basics and Art of Immunosuppression in Liver Transplantation.Journal of clinical and experimental hepatology
    Review
  12. Review
  13. Review
  14. Living-Donor Liver Transplantation-The Need for Greater Transparency.Journal of clinical and experimental hepatology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sanjay NagralDepartment of Surgical Gastroenterology, Jaslok Hospital and Research Centre, India.
Aditya NanavatiDepartment of General Surgery, K.B. Bhabha Municipal General Hospital, India.
Aabha NagralDepartment of Gastroenterology, Jaslok Hospital and Research Centre, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the liver transplant journey in India reaches substantial numbers and suggests quality technical expertise, it is time to dispassionately look at the big picture, identify problems, and consider corrective measures for the future. Several features characterize the current scenario. Although the proportion of deceased donor liver transplants is increasing, besides major regional imbalances, the activity is heavily loaded in favor of the private sector and live donor transplants. The high costs of the procedure, the poor participation of public hospitals, the lack of a national registry, and outcomes reporting are issues of concern. Organ sharing protocols currently based on chronology or institutional rotation need to move to a more justiciable severity-based system. Several measures can expand the deceased donor pool. The safety of the living donor continues to need close scrutiny and focus. Multiple medical challenges unique to the Indian situation are also being thrown up. Although many of the deficits demand state intervention and policy changes the transplant community needs to take notice and highlight them. The future of liver transplantation in India should move toward a more accountable, equitable, and accessible form. We owe this to our citizens who have shown tremendous faith in us by volunteering to be living donors as well as consenting for deceased donation.

Indexed as

ALF, acute liver failureCMV, cytomegalovirusCT, computerized tomographyDBD, donation after brain deathDCD, donation after cardiac deathDDLT, deceased donor liver transplantDNA, deoxyribonucleic aciddonation after brain deathHCC, hepatocellular carcinomaHCV, hepatitis C virusHOTA, Human Organs Transplant ActICU, intensive care unitINASL, Indian Association for Study of the LiverIndiaISOT, Indian Society of Organ TransplantationKCH, King's College HospitalLDLT, live donor liver transplantationliver transplantationliving donor liver transplantLT, liver transplantationMELD, model for end stage liver diseaseNASH, non-alcoholic steatohepatitisNGO, non-governmental organizationsNOTTO, National Organ and Tissue Transplant OrganizationNTORC, non transplant organ retrieval centerOPTN, Organ Procurement Transplant NetworkRGJAY, Rajiv Gandhi JeevandayeeArogyaYojanaROTTO, Regional Organ and Tissue Transplant OrganizationSOTTO, State Organ and Tissue Transplant OrganizationSRTR, Scientific Registry of Transplant RecipientsTB, tuberculosisUCSF, University of California San FranciscoUKELD, United Kingdom End stage Liver DiseaseUKNHSBT, UK the National Health Services Blood and Transplant AuthorityUK, United KingdomUNOS, United Network for Organ SharingUSA, United States of AmericaZTCC, Zonal Transplant Coordination Centre

Identifiers

PMID26900275
PMCPMC4723645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.